Cheng, Lesley ORCID: 0000-0002-8075-6144, Quek, Camelia YJ, Hung, Lin W, Sharples, Robyn A, Sherratt, Nicki A, Barnham, Kevin J ORCID: 0000-0003-1164-9465 and Hill, Andrew F ORCID: 0000-0001-5581-2354 (2016) Gene dysregulation is restored in the Parkinson's disease MPTP neurotoxic mice model upon treatment of the therapeutic drug CuII (atsm). Scientific Reports, 6. ISSN 2045-2322

Abstract

The administration of MPTP selectively targets the dopaminergic system resulting in Parkinsonism-like symptoms and is commonly used as a mice model of Parkinson's disease. We previously demonstrated that the neuroprotective compound CuII (atsm) rescues nigral cell loss and improves dopamine metabolism in the MPTP model. The mechanism of action of CuII (atsm) needs to be further defined to understand how the compound promotes neuronal survival. Whole genome transcriptomic profiling has become a popular method to examine the relationship between gene expression and function. Substantia nigra samples from MPTP-lesioned mice were evaluated using whole transcriptome sequencing to investigate the genes altered upon CuII (atsm) treatment. We identified 143 genes affected by MPTP lesioning that are associated with biological processes related to brain and cognitive development, dopamine synthesis and perturbed synaptic neurotransmission. Upon CuII (atsm) treatment, the expression of 40 genes involved in promoting dopamine synthesis, calcium signaling and synaptic plasticity were restored which were validated by qRT-PCR. The study provides the first detailed whole transcriptomic analysis of pathways involved in MPTP-induced Parkinsonism. In addition, we identify key therapeutic pathways targeted by a potentially new class of neuroprotective agents which may provide therapeutic benefits for other neurodegenerative disorders.

Search Google Scholar

Repository staff login